Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elderly AML Patients”

184 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 184 results

Testing effectiveness (Phase 2)Looking for participantsNCT07514936
What this trial is testing

Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia

Who this might be right for
Newly Diagnosed Acute Myeloid Leukemia (AML)Elderly Patients
Chinese PLA General Hospital 120
Not applicableStudy completedNCT01421875
What this trial is testing

Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 257
Testing effectiveness (Phase 2)Study completedNCT00590187
What this trial is testing

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Who this might be right for
Acute Myeloid Leukemia
Cyclacel Pharmaceuticals, Inc. 105
Large-scale testing (Phase 3)Study completedNCT01237808
What this trial is testing

Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation

Who this might be right for
Acute Myeloid Leukemia (AML)
University of Ulm 144
Early research (Phase 1)Ended earlyNCT03483948
What this trial is testing

Phase I Study of HMPL-523+Azacitidine in Elderly Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Hutchison Medipharma Limited 7
Testing effectiveness (Phase 2)UnknownNCT04752527
What this trial is testing

Individualized Induction Therapy for Non-elderly Acute Myeloid Leukemia Patients With Adverse Risk Features

Who this might be right for
Acute Myeloid Leukemia, Adult
The First Affiliated Hospital of Soochow University 42
Not applicableUnknownNCT01966497
What this trial is testing

Observational Study of Patients Older Than 60 Years With Acute Myeloblastic Leukemia

Who this might be right for
Acute Myeloblastic LeukemiaAged Higher Than 60 Years Old
Assistance Publique - Hôpitaux de Paris 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04476199
What this trial is testing

Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Trapianto di Midollo Osseo 100
Post-approval studies (Phase 4)Study completedNCT00180167
What this trial is testing

Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC

Who this might be right for
Leukemia, Nonlymphocytic, Acute
Technische Universität Dresden 492
Testing effectiveness (Phase 2)Study completedNCT00602771
What this trial is testing

Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
National Cancer Institute (NCI) 84
Large-scale testing (Phase 3)UnknownNCT04083911
What this trial is testing

Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60

Who this might be right for
Acute Myeloid LeukemiaInduction Chemotherapy
The First Affiliated Hospital of Soochow University 50
Testing effectiveness (Phase 2)Study completedNCT00017589
What this trial is testing

Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Genta Incorporated
Large-scale testing (Phase 3)Not Yet RecruitingNCT07469046
What this trial is testing

VAH vs VA in Newly Diagnosed Elderly AML

Who this might be right for
Acute Myeloid Leukemia (AML)Elderly Patients (60-75 Years)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 308
Not applicableNot Yet RecruitingNCT07420790
What this trial is testing

Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III Trial

Who this might be right for
Acute Myeloid Leukemia
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 1,941
Not applicableNot Yet RecruitingNCT07201233
What this trial is testing

Clinical Study on the Safety and Efficacy of Umbilical Cord Blood Infusion in Treating Bone Marrow Suppression .

Who this might be right for
Bone Marrow Suppression
Shandong Qilu Stem Cells Engineering Co., Ltd. 30
Testing effectiveness (Phase 2)Temporarily pausedNCT01010373
What this trial is testing

Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
BioMAS Ltd 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03573024
What this trial is testing

Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University of Colorado, Denver 36
Testing effectiveness (Phase 2)Ended earlyNCT03381118
What this trial is testing

Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
St. Petersburg State Pavlov Medical University 16
Not applicableUnknownNCT02698124
What this trial is testing

Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice

Who this might be right for
Acute Myeloid LeukemiaElderlyIntensive Chemotherapy Unfit
Ulsan University Hospital 136
Large-scale testing (Phase 3)Study completedNCT02473146
What this trial is testing

Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4

Who this might be right for
Acute Myeloid Leukemia
Versailles Hospital 225
Load More Results